Kestra Advisory Services
SLS icon

Kestra Advisory Services’s SELLAS Life Sciences SLS Stock Holding History

Kestra Advisory Services’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.53M Buy
124,425
+89,445
+256% +$1.12M ﹤0.01% 1648
2026
Q2 		$516K Buy
34,980
+5,830
+20% +$40.2K ﹤0.01% 2321
2026
Q1 		$123K Buy
29,150
+1,750
+6% +$7.83K ﹤0.01% 3008
2025
Q4 		$103K Buy
27,400
+1,000
+4% +$1.94K ﹤0.01% 3393
2025
Q3 		$42.5K Buy
+26,400
New +$47K ﹤0.01% 2867

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Fulcrum Wealth Advisors
Fulcrum Wealth Advisors Bellevue, Washington $144M AUM 21.17% 1-Year Est. Return

Kestra Advisory Services's SLS Position: Q3 2026 in Review

Kestra Advisory Services increased its SELLAS Life Sciences (SLS) stake by 256% in Q3 2026, buying an estimated $1.12M and bringing the position to 124,425 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Kestra Advisory Services first reported a position in SLS in Q3 2025 and has held it in 5 quarters since. 67 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Kestra Advisory Services held 124,425 shares of SELLAS Life Sciences worth $1.53M as of Q3 2026.
  • Kestra Advisory Services bought 89,445 SELLAS Life Sciences shares in Q3 2026, an estimated $1.12M.
  • SELLAS Life Sciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #1648 holding.
  • Kestra Advisory Services first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 5 quarters since.
  • 67 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.